Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ITRM
- Price
- 1.11
- Stock movement up
- +0.01 (0.91%)
- Company name
- Iterum Therapeutics PLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 30.54M
- Ent value
- 44.57M
- Price/Sales
- 11.66
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -53.23%
- 1 year return
- -32.32%
- 3 year return
- -39.06%
- 5 year return
- -51.20%
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ITRM does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.66 |
| Price to Book | - |
| EV to Sales | 17.01 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 27.52M |
| EPS (TTM) | -1.52 |
| FCF per share (TTM) | -1.74 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.62M |
| Gross profit (TTM) | 2.17M |
| Operating income (TTM) | -26.46M |
| Net income (TTM) | -30.55M |
| EPS (TTM) | -1.52 |
| EPS (1y forward) | -0.82 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 82.63% |
| Operating margin (TTM) | -1009.81% |
| Profit margin (TTM) | -1166.18% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 13.41M |
| Net receivables | 274.00K |
| Total current assets | 15.85M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 363.00K |
| Total assets | 15.92M |
| Accounts payable | 835.00K |
| Short/Current long term debt | 22.44M |
| Total current liabilities | 18.70M |
| Total liabilities | 27.43M |
| Shareholder's equity | -11.51M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -34.89M |
| Capital expenditures (TTM) | 2.16K |
| Free cash flow (TTM) | -34.89M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -191.87% |
| Return on Invested Capital | -279.57% |
| Cash Return on Invested Capital | -319.28% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.11 |
| Daily high | 1.13 |
| Daily low | 1.09 |
| Daily Volume | 203K |
| All-time high | 185.25 |
| 1y analyst estimate | 7.50 |
| Beta | 2.25 |
| EPS (TTM) | -1.52 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ITRM | S&P500 | |
| Current price drop from All-time high | -99.40% | -12.89% |
| Highest price drop | -99.65% | -56.47% |
| Date of highest drop | 25 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -83.57% | -11.07% |
| Avg time to new high | 345 days | 12 days |
| Max time to new high | 1710 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
30.54M
Marketcap category
Small-cap
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Employees
14
Website
Investor relations
-
SEC filings
CEO
Corey N. Fishman
Country
USA
City
Dublin
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page